Latest Articles

A novel microfluidic platform, able to rapidly isolate and identify rare antibodies from a vast repertoire of human B cells, has been developed by scientists. This technology could possess the ability to support and enhance the development of novel vaccines and biopharmaceuticals in the future.

Although cannabis for human consumption or smoking should be as free from heavy metal contamination as possible, that’s not always the case.

Although cannabis for human consumption or smoking should be as free from heavy metal contamination as possible, that’s not always the case.

Awareness of Artificial Intelligence (AI), Machine Learning (ML) and Neuro-linguistic Programming (NLP) is ever-increasing, with AI being one of the most talked about technologies across multiple industries. The Pistoia Alliance recently surveyed 374 life science professionals to determine the impact of AI, ML and NLP on the life sciences industry.

Using light instead of electrodes is non-invasive, high-throughput and represents the successor to traditional electrophysiology.

With UK Prime Minister Theresa May announcing today that UK supermarkets must have a plastic free aisle as part of her government’s 25-year environmental improvement plan, it is the latest in a line of reforms seeking to reduce the harmful plastic contamination that has become a worldwide scourge.

The Blue Brain Nexus is designed to facilitate the recording, curating, storing, describing and tracking of experimental and computational neuroscience data in a format that may enable researchers to build a truly comprehensive picture of the brain.

The Blue Brain Project is an attempt to reverse engineer the rodent brain (and ultimately, the human brain) and recreate it at the cellular level inside a computer simulation.

Continuous cell culture is part of a trend in bioprocessing towards highly productive, streamlined, and interconnected unit operations. While continuous processing has a long history in various industries, regulatory concerns have stalled widespread adoption of continuous bioprocessing. That is beginning to change as the industry acclimates to regulators’ desire for risk- and science-based production decisions.

This year’s BNA Christmas symposium focus was on neurotechnologies and their place in society.